Click any KPI, stage, or HCC row to drill into member-level detail.
Opportunities closed MTD
+4.5%1,289
of 1,495 identified this month
Avg days to close
+3.1%38 days
Target: ≤ 30 days79% to goal
Opportunity lifecycle pipeline
Every actionable opportunity from identification through closure — current open volume by stage
65% conversion
71% conversion
65% conversion
85% conversion
84% conversion
Total capture rate21.3%
Volume still in pipeline3,008 opportunities
On-time closure rate vs target
Current year vs prior year
Identified vs closed vs on time
Monthly volume
Open opportunity aging
3,325 open · 318 past due
0-30 days
1,482
31-60 days
921
61-90 days
604
90+ days
318
Top closure blockers
Where opportunities stall, and what it costs in RAF
| Blocker | Stage | Opportunities | RAF held |
|---|---|---|---|
| Member unreachable after 3 attempts | Outreach | 412 | 0.084 |
| Visit scheduled beyond measurement year | Scheduled | 287 | 0.061 |
| Condition not clinically supported in note | Documented | 214 | 0.048 |
| Specialist-only diagnosis, no PCP confirmation | Documented | 168 | 0.037 |
| Encounter rejected by payor edit | Submitted | 96 | 0.021 |
Actionable opportunities by HCC category
Recapture and suspecting combined · click a row for member-level detail
| HCC | Condition | Open | Closed YTD | RAF weight | RAF at stake | Closure |
|---|---|---|---|---|---|---|
| HCC 19 | Diabetes without complication | 486 | 612 | 0.104 | 50.5 | |
| HCC 18 | Diabetes with chronic complications | 312 | 405 | 0.302 | 94.2 | |
| HCC 111 | Chronic obstructive pulmonary disease | 274 | 338 | 0.328 | 89.9 | |
| HCC 85 | Congestive heart failure | 241 | 366 | 0.331 | 79.8 | |
| HCC 138 | Chronic kidney disease, stage 4 | 158 | 187 | 0.289 | 45.7 | |
| HCC 12 | Breast, prostate, and other cancers | 121 | 144 | 0.150 | 18.1 |